Literature DB >> 19100823

Inhibition of breast cancer metastasis by dual liposomes to disturb complex formation.

Jane Wenzel1, Reiner Zeisig, Iduna Fichtner.   

Abstract

The interaction between tumour cells and blood components, mainly platelets, plays an important role in metastasis. In this study, the anti-metastatic effect of vesicles containing the cytotoxic drug perifosine (OPP) and the haemostatic inhibitor dipyridamole (DIP) was tested. These dual liposomes (DIP/OPP-L) encapsulating up to 400microg DIP/ml and 6mM OPP were prepared by extrusion technique. In vitro, DIP/OPP-L significantly inhibited the aggregation of platelets and reduced their adhesion to immobilized MT3 cells by up to 60% and 24.7%, respectively. Complex formation between platelets and tumour cells in vitro was completely prevented by DIP/OPP-vesicles. These combinatory liposomes also inhibited the metastatic capacity of circulating tumour cells by reducing the complex formation with platelets. Formation of lung and extrapulmonary metastases after intravenous administration of MT3 breast cancer cells was significantly reduced when mice were treated with a single intravenous dose of DIP/OPP-L containing 100nmol lipid 6h before tumour cell inoculation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19100823     DOI: 10.1016/j.ijpharm.2008.11.023

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  3 in total

1.  Dipyridamole prevents triple-negative breast-cancer progression.

Authors:  Daniela Spano; Jean-Claude Marshall; Natascia Marino; Daniela De Martino; Alessia Romano; Maria Nunzia Scoppettuolo; Anna Maria Bello; Valeria Di Dato; Luigi Navas; Gennaro De Vita; Chiara Medaglia; Patricia S Steeg; Massimo Zollo
Journal:  Clin Exp Metastasis       Date:  2012-07-04       Impact factor: 5.150

2.  Inhibition of metastasis in a murine 4T1 breast cancer model by liposomes preventing tumor cell-platelet interactions.

Authors:  Jane Wenzel; Reiner Zeisig; Iduna Fichtner
Journal:  Clin Exp Metastasis       Date:  2009-11-15       Impact factor: 5.150

3.  Recent trends in multifunctional liposomal nanocarriers for enhanced tumor targeting.

Authors:  Federico Perche; Vladimir P Torchilin
Journal:  J Drug Deliv       Date:  2013-03-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.